Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?
Research output: Contribution to journal › Article
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Expert Review of Neurotherapeutics|
|Publication status||Published - 2011|
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Neuronal Survival (013212041)